Perspectives on the diagnosis and treatment of the relapsed/refractory multiple myeloma: highlight of the 19th European Hematology Association annual congress / 白血病·淋巴瘤

ABSTRACT

Relapsed/refractory multiple myeloma (MM) is always a challenge in the field of MM treatment.In the 19th European Hematology Association (EHA) annual congress,there was a detailed and full-length description on the definition,prognosis,therapeutic strategies and new drugs of the relapsed/refractory MM.New agents with activity and good tolerability are promising in the future.